Area of research
Oncology · Surgery
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Inflammatory Biomarkers in Disease Prognosis, Coronary Interventions and Diagnostics, and Sepsis Diagnosis and Treatment.
MLKL–Mediated Necroptosis Predominantly Contributes to Immune-Associated Myocardial Damage
Development of peripheral biomarker-based prognostic nomograms for short-term and long-term survival in immune checkpoint inhibitor-associated myocarditis
Development and validation of a nomogram for predicting in-hospital mortality in older adult hip fracture patients with atrial fibrillation: a retrospective study
Analysis of risk factors and development of a prediction model for long-term prognosis in patients with ischemic heart failure after percutaneous coronary intervention
Correction: Nomograms based on ratio indexes to predict severity and prognosis in immune checkpoint inhibitors-related myocarditis: a retrospective analysis
Evaluation of the effectiveness and safety of preoperative drug elution balloon therapy in patients with elective tumor surgery and coronary heart disease: a retrospective clinical study
Blood-derived ratio indexes associated with severity and prognosis of immune checkpoint inhibitor-related cardiotoxicity: a retrospective analysis
Interpretable Machine Learning Approach for Predicting 30-Day Mortality of Critical Ill Patients with Pulmonary Embolism and Heart Failure: A Retrospective Study
Peripheral biomarkers to assess risk, severity, and prognosis of immune checkpoint inhibitor-associated myocarditis: a retrospective clinical study
Nomograms based on ratio indexes to predict severity and prognosis in immune checkpoint inhibitors-related myocarditis: a retrospective analysis
Analysis of risk factors and development of prediction model for improvement of ejection fraction in patients with ischemic cardiomyopathy after percutaneous coronary intervention: a case control study